Dougherty & Co Starts Intuitive Surgical (ISRG) at Buy; Healthy Market for Da Vinci

Dougherty & Co initiates coverage on Intuitive Surgical (NASDAQ: ISRG) with a Buy. PT $650.00.

Analyst, Junaid Husain, said, "ISRG is a pure-play leader in the field of minimally invasive robotic surgery with its chief product, the da Vinci System. Our Buy recommendation is predicated on the following: 1) We See a Healthy Market for the da Vinci System; 2) Pipeline in a Platform Drives Clinical Utilization; 3) We Think a Next-Generation da Vinci System is Around the Corner; and 4) Rich Valuation Reasonable."

For an analyst ratings summary and ratings history on Intuitive Surgical click here. For more ratings news on Intuitive Surgical click here.

Shares of Intuitive Surgical closed at $539.07 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Oppenheimer Upgrades Intuitive Surgical (ISRG) to Outperform, 'Crowding Out Competitors Strategically Smart'
• Jefferies Starts Aehr Test Systems (AEHR) at Buy
• ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)